Egrifta (Tesamorelin) South Asian Dose Adjustments
Evidence-based guide to tesamorelin dosing considerations for South Asian patients, including pharmacogenomic factors, metabolic risk differences, and clinical monitoring recommendations.
Testosterone Enanthate Safety Profile Differences in Black / African Ancestry Patients
Evidence-based review of how testosterone enanthate safety, metabolism, and monitoring differ in Black and African ancestry men, including cardiovascular risk, CKD screening, G6PD prevalence, and pharmacogenomic considerations.
Testosterone Enanthate in South Asian Patients: Safety Profile Differences
How South Asian genetics, metabolic risk, and pharmacogenomic variation affect testosterone enanthate safety, dosing, and monitoring. Evidence-based guide with clinical recommendations.
Thymosin Alpha-1 Dose Adjustments for Black / African Ancestry Patients
Evidence-based guide to thymosin alpha-1 (thymalfasin) dosing considerations in Black and African ancestry populations, covering pharmacogenomics, immune response variability, and clinical monitoring.
Thymosin Alpha-1 in East Asian Patients: Documented Efficacy Gaps and Pharmacogenomic Considerations
Evidence-based review of Thymosin Alpha-1 (thymalfasin) efficacy differences in East Asian populations, including pharmacogenomic factors, HBV trial data, and dosing considerations.
Thymosin Alpha-1 in South Asian Patients: Documented Efficacy Gaps and Pharmacogenomic Considerations
Evidence-based review of Thymosin Alpha-1 (thymalfasin) efficacy differences in South Asian populations, covering pharmacogenomics, dosing considerations, immune response variation, and clinical trial subgroup data.
Tretinoin Safety in Black and African Ancestry Patients: What the Evidence Shows
Black and African ancestry patients face distinct tretinoin safety considerations, including higher post-inflammatory hyperpigmentation risk and irritation patterns. Evidence-based guidance on dosing, formulation choice, and monitoring.
Viagra (Sildenafil) Safety in Black / African Ancestry Patients: What the Data Show
Evidence-based review of sildenafil safety differences in Black and African ancestry patients, covering pharmacogenomics, cardiovascular risk, G6PD, dosing, and drug interactions.
Wegovy South Asian Dose Adjustments: What Prescribers and Patients Need to Know
Evidence-based guide to Wegovy (semaglutide 2.4 mg) dosing considerations for South Asian patients, including BMI thresholds, pharmacogenomic factors, and titration guidance.
Zepbound (Tirzepatide) Dose Adjustments for Black / African Ancestry Patients
Evidence-based guide to Zepbound (tirzepatide) dosing considerations for Black and African ancestry patients, including pharmacogenomic factors, clinical trial subgroup data, and hypertension comorbidity management.
Zepbound (Tirzepatide) Safety Profile Differences in East Asian Patients
Evidence-based review of how Zepbound (tirzepatide) safety, tolerability, dosing, and pharmacokinetics differ in East Asian populations, including SURMOUNT and SURPASS-J trial data.
Zepbound (Tirzepatide) Dose Adjustments for Hispanic and Latino Patients
Evidence-based guide to Zepbound (tirzepatide) dosing considerations for Hispanic and Latino patients, covering pharmacogenomic factors, clinical trial subgroup data, and practical titration guidance.
Zepbound in Hispanic and Latino Patients: Documented Efficacy Differences
Evidence-based review of how Zepbound (tirzepatide) performs in Hispanic and Latino populations, including SURMOUNT trial subgroup data, pharmacogenomic considerations, and dosing guidance.
Finasteride Pediatric (Under 12) Dosing: What Clinicians and Parents Need to Know
Finasteride has no FDA-approved pediatric dosing for children under 12. Learn why this 5-alpha reductase inhibitor is contraindicated in prepubertal patients, what the evidence says, and when rare exceptions may apply.
Finasteride Switching Protocols: How to Transition From or To Other Drugs in Class
Evidence-based protocols for switching between finasteride, dutasteride, minoxidil, and combination therapies for hair loss (AGA) and BPH, with MD-level clinical guidance and PubMed-cited sources.
Addyi (Flibanserin) Regulatory Status: US, EU, Canada, and UK
A clinician-level review of flibanserin (Addyi) regulatory approvals and rejections across the US, EU, Canada, and UK, including trial data, REMS requirements, and prescribing restrictions.
Addyi (Flibanserin) Safety Signals and FDA Actions: A Clinical Timeline
A detailed review of flibanserin (Addyi) safety signals, FDA rejections, REMS requirements, alcohol interaction warnings, and post-marketing surveillance data for HSDD treatment.
Switching From or To Flibanserin (Addyi): Protocols, Timelines, and What to Expect
Evidence-based guide to switching from flibanserin (Addyi) to bremelanotide (Vyleesi) or other HSDD treatments, including washout periods, dose adjustments, and clinical monitoring.
Do I Need to Follow a Strict Diet While on Ozempic?
A strict diet is not required on Ozempic, but specific eating patterns improve weight loss and reduce side effects. Learn what to eat, what to avoid, and how to structure meals while taking semaglutide.
Does Aetna Cover Trulicity? Formulary Status, Prior Authorization, and Cost Breakdown
Find out whether Aetna covers Trulicity (dulaglutide), including formulary tier placement, prior authorization requirements, copay ranges, and alternative GLP-1 options under Aetna plans.
Does Blue Cross Blue Shield of Alabama Cover Trulicity?
Find out whether Blue Cross Blue Shield of Alabama covers Trulicity (dulaglutide), what formulary tier it falls on, prior authorization requirements, and how to reduce your out-of-pocket cost.
Does Blue Cross Blue Shield of Illinois Cover Saxenda?
Find out whether Blue Cross Blue Shield of Illinois covers Saxenda (liraglutide 3.0 mg) for weight loss, including prior authorization requirements, step therapy rules, and alternatives if coverage is denied.
Does Blue Cross Blue Shield of Illinois Cover Semaglutide (Wegovy)?
Find out whether Blue Cross Blue Shield of Illinois covers Wegovy (semaglutide 2.4 mg) for weight loss, what prior authorization criteria apply, and how to improve your chances of approval.
Does Blue Cross Blue Shield of Illinois Cover Tirzepatide (Mounjaro)?
Find out whether Blue Cross Blue Shield of Illinois covers tirzepatide (Mounjaro) for type 2 diabetes and weight loss, including formulary status, prior authorization requirements, and cost-saving alternatives.
Does Blue Cross Blue Shield of Michigan Cover Ozempic?
Find out whether Blue Cross Blue Shield of Michigan covers Ozempic (semaglutide), what prior authorization criteria apply, expected copays, and how to appeal a denial.
Does Blue Cross Blue Shield of North Carolina Cover Saxenda?
Find out if Blue Cross Blue Shield of North Carolina (BCBSNC) covers Saxenda (liraglutide 3.0 mg) for weight loss, including prior authorization criteria, copay estimates, step therapy requirements, and how to appeal a denial.
Does Blue Cross Blue Shield of North Carolina Cover Semaglutide (Wegovy)?
Find out if BCBSNC covers Wegovy (semaglutide 2.4 mg) for weight loss, including prior authorization criteria, step therapy requirements, copay estimates, and appeal options.
How Can I Tell If a Pharmacy or Medication Is FDA-Approved?
Learn how to verify FDA approval for medications and legitimacy of pharmacies using official databases, NABP accreditation, and state licensing boards.
Is Mounjaro a GLP-1? Yes, and More Than One
Mounjaro activates both GIP and GLP-1 receptors, unlike standard GLP-1 drugs, leading to greater weight loss and A1C reduction in trials.
How GLP-1s Like Semaglutide Help with Impulse Control
GLP-1 receptor agonists such as semaglutide affect dopamine reward circuits in the brain, reducing impulsive behaviors around food, alcohol, and other compulsive habits. Here is what the science shows.
How Much Is Mounjaro Without Insurance? Tirzepatide Cost Breakdown
Mounjaro (tirzepatide) costs $1,023, $1,462 per month without insurance. Learn about list prices by dose, savings programs, compounded alternatives, and ways to reduce out-of-pocket spending.
Is Microdosing GLP-1s All Hype? What the Evidence Actually Shows
Microdosing GLP-1 receptor agonists like semaglutide and tirzepatide has gained social media traction, but clinical trial data tells a more complicated story. Here is what physicians and the research say about sub-therapeutic GLP-1 dosing.
Is Wegovy Covered by Insurance?
A detailed breakdown of Wegovy insurance coverage by plan type, including Medicare, Medicaid, commercial plans, prior authorization requirements, and cost-saving alternatives.
What Are Peptides? A Women's Health Guide
Peptides are short chains of amino acids that regulate hormones, metabolism, bone density, and more. This evidence-based guide explains how peptides work in women's health, which ones are FDA-approved, and what the research actually shows.
What Is Saxenda (Liraglutide)? Dosing, Weight Loss Data, Cost, and How It Compares
Saxenda (liraglutide 3.0 mg) is an FDA-approved GLP-1 receptor agonist for chronic weight management. Learn about dosing, clinical trial results, side effects, cost, and how it compares to semaglutide.
What You Should Know About Microdosing Ozempic (Semaglutide)
Microdosing Ozempic means using semaglutide at doses below the FDA-approved titration schedule. Learn what the evidence says, the risks involved, and why clinicians advise caution.
Why Does Calibrate Prescribe Wegovy (Semaglutide)? Clinical Rationale and Program Details
Calibrate prescribes Wegovy (semaglutide 2.4 mg) as part of a metabolic health program combining GLP-1 therapy with lifestyle coaching. Learn the clinical evidence behind this approach.
What Are Peptides? Types, Benefits, and Uses in Medicine
Peptide is a chemical description, not a safety rating. Compare approved peptide drugs, investigational molecules, compounded preparations, and research products by evidence and product status.
Do I Need a Referral From My Clinician to Join Calibrate?
No referral is required to join Calibrate. Learn how Calibrate's direct-to-consumer enrollment works, what the program includes, GLP-1 eligibility criteria, insurance considerations, and how to get started with metabolic health treatment.
How 9amHealth Works: Virtual Diabetes Care, Lab Testing, and Medication Delivery Explained
A detailed breakdown of how 9amHealth's virtual diabetes and metabolic health platform works, including at-home lab testing, medication management, endocrinologist access, and ongoing coaching.
How Do GLP-1 Medications Work?
GLP-1 receptor agonists mimic the incretin hormone GLP-1 to increase insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite. This guide covers the pharmacology, clinical evidence, and practical use of semaglutide, tirzepatide, liraglutide, and dulaglutide.
Calibrate Withings Scale: Step-by-Step Setup Guide
Pair your Withings scale via Bluetooth in the Health Mate app, connect Wi-Fi, then sync weigh-ins to Calibrate. Setup takes about 5 minutes.
How Quickly Do GLP-1 Medications Start Working?
GLP-1 receptor agonists like semaglutide and tirzepatide begin lowering blood sugar within hours, but meaningful weight loss takes 4 to 12 weeks. Here is what to expect week by week.
How to Find the Right Nutrition Coach for You
A clinical guide to choosing a qualified nutrition coach, including credential types, red flags, insurance coverage, and evidence-based criteria for matching your health goals to the right provider.
How to Take Body Circumference Measurements
A clinical guide to accurate body circumference measurements, including waist, hip, neck, and limb sites, with technique steps, error-prevention tips, and metabolic risk cutoffs from WHO and NHLBI guidelines.
How UFC Fighters Train, Recover, and Fuel for Peak Performance in 2025
Evidence-based breakdown of the training periodization, recovery protocols, and nutrition strategies elite UFC fighters use to optimize performance, cut weight safely, and extend career longevity.
Is a Genetic Methylation Test Worth It? A Guide
A guide to genetic methylation testing, MTHFR variants, and whether these tests change medical outcomes. Covers cost, accuracy, clinical guidelines, and who may benefit.
Can You Catch Up on Sleep? What It Fixes and Doesn't
Yes, but only partly. Recovery sleep eases sleepiness fast, while attention and insulin sensitivity take longer to normalize than one long lie-in allows.
What If I Have a GLP-1 Prescription from My Personal Doctor?
Already have a GLP-1 prescription from your own physician? Learn how metabolic health programs handle outside prescriptions, what changes for insurance coverage, and whether combining a structured program with your existing Rx improves long-term outcomes.
What Role Should Employers Play in Supporting Employee Health Beyond Providing Insurance Coverage?
Evidence-based strategies employers can use to support workforce health beyond traditional insurance, including mental health programs, preventive screening, workplace design, and financial wellness initiatives.
Why Weight-Loss Meds Are Stigmatized: A Health View
Weight-loss medications face deep-rooted stigma despite strong clinical evidence. This article examines why anti-obesity drugs are stigmatized, the science behind obesity as a chronic disease, and how bias affects patient outcomes.
BPC-157 Effect on AST: What the Research Shows
Does BPC-157 raise or lower AST? We review the preclinical evidence on BPC-157 pentadecapeptide and aspartate aminotransferase, explain the proposed mechanism, and outline a practical monitoring schedule.
Enclomiphene Citrate Effect on LH: Mechanism, Magnitude, and Monitoring
Enclomiphene citrate raises LH by blocking hypothalamic estrogen receptors. Learn the expected magnitude of LH increase, time course, clinical trial data, and when to check labs.
How Mounjaro Affects AST Levels
Tirzepatide (Mounjaro) can lower AST in many patients by reducing hepatic steatosis, but transient AST elevations also occur. Learn the clinical data, monitoring schedule, and what your numbers mean.
How Ozempic Affects Fasting Glucose: Mechanism, Magnitude, and Monitoring
Ozempic (semaglutide) lowers fasting glucose by 1.2 to 2.8 mmol/L in type 2 diabetes. Learn the mechanism, timeline, trial data from SUSTAIN, and when to check your levels.
How Zepbound Affects HbA1c: Clinical Data on Tirzepatide and Glycemic Control
Zepbound (tirzepatide) lowers HbA1c by 0.3 to 2.4 percentage points depending on baseline glucose status. Review the SURMOUNT trial data, mechanism, monitoring schedule, and what to expect.
Hormone Replacement Therapy: Complete 2026 Guide
Evidence-based guide to hormone replacement therapy (HRT) covering estrogen, progesterone, testosterone, delivery methods, risks, monitoring, and treatment selection for menopause and hypogonadism.
Osteoporosis Treatment: A Doctor's Guide for 2026
Evidence-based guide to osteoporosis diagnosis, medications, monitoring, and prevention. Covers bisphosphonates, denosumab, romosozumab, teriparatide, and lifestyle interventions with trial data and dosing details.
Type 2 Diabetes: A Doctor's Guide for 2026
Evidence-based guide to type 2 diabetes treatments in 2026, covering metformin, GLP-1 receptor agonists, SGLT2 inhibitors, insulin, and emerging therapies with head-to-head comparisons and monitoring protocols.
Alprostadil (Caverject/MUSE) and SNRIs (Venlafaxine, Duloxetine): Drug Interaction Guide
Clinical guide to combining alprostadil (Caverject/MUSE) with SNRIs like venlafaxine and duloxetine. Covers mechanism, blood pressure risks, monitoring, dose adjustments, and patient counseling.
